SAPPHIRE: Phase III study of sitravatinib plus nivolumab versus docetaxel in patients with previously treated advanced non-squamous non-small cell lung cancer (NSCLC)

被引:2
作者
Borghaei, H. [1 ]
Johnson, M. L. [2 ]
Garon, E. B. [3 ]
He, K. [4 ]
Planchard, D. [5 ]
Reck, M. [6 ]
Popat, S. [7 ]
Herbst, R. S. [8 ]
Leal, T. A. [9 ]
Dumoulin, D. [10 ]
De Marinis, F. [11 ]
Reynolds, C. H. [12 ]
Theelen, W. S. M. E. [13 ]
Percent, I. [14 ]
Calderon, V. Gutierrez [15 ]
Flandin, A. C. Madroszyk [16 ]
Shazer, R. L. [17 ]
Yan, X. [18 ]
Harrigan, R. [19 ]
Peters, S. [20 ]
机构
[1] Fox Chase Canc Ctr, Hematol & Oncol, Philadelphia, PA USA
[2] Tennessee Oncol, Lung Canc Res, Sarah Cannon Res Inst, Nashville, TN USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[4] Ohio State Univ, Comprehens Canc Ctr, Pelotonia Ins Immuno Oncol, Columbus, OH USA
[5] Inst Gustave Roussy, Dept Thorac Oncol, Villejuif, France
[6] LungenClin Grosshansdorf, Thorac Oncol, Grosshansdorf, Germany
[7] Royal Marsden Hosp NHS Fdn Trust, Dept Med, London, England
[8] Yale Univ, Med Oncol, New Haven, CT USA
[9] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[10] Erasmus Med Centrum, Pulmonary Dis, Rotterdam, Netherlands
[11] European Inst Oncol, Thorac Oncol Dept, IRCC, Milan, Italy
[12] Florida Canc Specialists & Res Inst North Region, Oncol Dept, Ocala, FL USA
[13] Netherlands Canc Inst, Thorac Oncol, Amsterdam, Netherlands
[14] Florida Canc Specialists & Res Inst South Region, Oncol, Ft Myers, FL USA
[15] Hosp Reg Univ Malaga, Med Oncol, Malaga, Spain
[16] Inst Paoli Calmettes, Dept Med, Marseille, France
[17] Mirati Therapeut Inc, Res & Dev, San Diego, CA USA
[18] Mirati Therapeut Inc, Clin Dev, San Diego, CA USA
[19] Mirati Therapeut Inc, Clin Res, San Diego, CA USA
[20] CHU Vaudois, Med Oncol, Lausanne, Switzerland
关键词
D O I
10.1016/j.annonc.2023.10.064
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LBA63
引用
收藏
页码:S1308 / S1308
页数:1
相关论文
empty
未找到相关数据